Gliadin amino acid sequence(s) responsible for toxicity in susceptible individuals have not been fully elucidated. Previous in vitro studies have suggested the presence of active sequences in the NH(2)-terminal part of the A-gliadin molecule. In this paper the in vitro activity of A-gliadin synthetic peptides 31-55, 31-43, and 44-55 has been investigated

In vitro activities of A-gliadin-related synthetic peptides - Damaging effect on the atrophic coeliac mucosa and activation of mucosal immune response in the treated coeliac mucosa / L., Maiuri; R., Troncone; M., Mayer; S., Coletta; A., Picarelli; M., De Vincenzi; Pavone, Vincenzo; S., Auricchio. - In: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. - ISSN 0036-5521. - STAMPA. - 31:(1996), pp. 247-253.

In vitro activities of A-gliadin-related synthetic peptides - Damaging effect on the atrophic coeliac mucosa and activation of mucosal immune response in the treated coeliac mucosa

R. Troncone;PAVONE, VINCENZO;
1996

Abstract

Gliadin amino acid sequence(s) responsible for toxicity in susceptible individuals have not been fully elucidated. Previous in vitro studies have suggested the presence of active sequences in the NH(2)-terminal part of the A-gliadin molecule. In this paper the in vitro activity of A-gliadin synthetic peptides 31-55, 31-43, and 44-55 has been investigated
1996
In vitro activities of A-gliadin-related synthetic peptides - Damaging effect on the atrophic coeliac mucosa and activation of mucosal immune response in the treated coeliac mucosa / L., Maiuri; R., Troncone; M., Mayer; S., Coletta; A., Picarelli; M., De Vincenzi; Pavone, Vincenzo; S., Auricchio. - In: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. - ISSN 0036-5521. - STAMPA. - 31:(1996), pp. 247-253.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/455922
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact